Diabetes in the elderly is metabolically distinct from diabetes in younger
people and the approach to therapy should be different.
Sulphonylureas should be used with caution because the risk of hypoglycemia
increases exponentially with age.
Long-acting basal analogues are associated with a lower frequency of
hypoglycemia than conventional insulins in this age group.
In elderly people, if mixture of insulin is required, the use of premixed
insulins as an alternative to mixing insulins minimizes dose errors.